General Information of Drug Off-Target (DOT) (ID: OTNEOJY7)

DOT Name Circadian locomoter output cycles protein kaput (CLOCK)
Synonyms hCLOCK; EC 2.3.1.48; Class E basic helix-loop-helix protein 8; bHLHe8
Gene Name CLOCK
Related Disease
Epilepsy ( )
Obstructive sleep apnea ( )
Adenoma ( )
Advanced cancer ( )
Alcohol dependence ( )
Alcohol withdrawal delirium ( )
Anxiety disorder ( )
Arteriosclerosis ( )
Atherosclerosis ( )
Bipolar depression ( )
Bipolar disorder ( )
Bone osteosarcoma ( )
Carcinoma ( )
Cholestasis ( )
Cluster headache ( )
Colorectal carcinoma ( )
Depression ( )
Epithelial ovarian cancer ( )
Gastric cancer ( )
Head-neck squamous cell carcinoma ( )
Hepatocellular carcinoma ( )
Insomnia ( )
Metabolic disorder ( )
Neoplasm ( )
Non-small-cell lung cancer ( )
Osteoarthritis ( )
Osteosarcoma ( )
Parkinson disease ( )
Rheumatoid arthritis ( )
Seasonal affective disorder ( )
Smith-Magenis syndrome ( )
Squamous cell carcinoma ( )
Stomach cancer ( )
Asthma ( )
Attention deficit hyperactivity disorder ( )
High blood pressure ( )
Acute myelogenous leukaemia ( )
Alcohol use disorder ( )
Melanoma ( )
Autism spectrum disorder ( )
Cocaine addiction ( )
Coronary heart disease ( )
Inflammatory bowel disease ( )
Mental disorder ( )
Myocardial infarction ( )
Pancreatic cancer ( )
UniProt ID
CLOCK_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
PDB ID
4H10; 6QPJ
EC Number
2.3.1.48
Pfam ID
PF00010 ; PF00989 ; PF14598
Sequence
MLFTVSCSKMSSIVDRDDSSIFDGLVEEDDKDKAKRVSRNKSEKKRRDQFNVLIKELGSM
LPGNARKMDKSTVLQKSIDFLRKHKEITAQSDASEIRQDWKPTFLSNEEFTQLMLEALDG
FFLAIMTDGSIIYVSESVTSLLEHLPSDLVDQSIFNFIPEGEHSEVYKILSTHLLESDSL
TPEYLKSKNQLEFCCHMLRGTIDPKEPSTYEYVKFIGNFKSLNSVSSSAHNGFEGTIQRT
HRPSYEDRVCFVATVRLATPQFIKEMCTVEEPNEEFTSRHSLEWKFLFLDHRAPPIIGYL
PFEVLGTSGYDYYHVDDLENLAKCHEHLMQYGKGKSCYYRFLTKGQQWIWLQTHYYITYH
QWNSRPEFIVCTHTVVSYAEVRAERRRELGIEESLPETAADKSQDSGSDNRINTVSLKEA
LERFDHSPTPSASSRSSRKSSHTAVSDPSSTPTKIPTDTSTPPRQHLPAHEKMVQRRSSF
SSQSINSQSVGSSLTQPVMSQATNLPIPQGMSQFQFSAQLGAMQHLKDQLEQRTRMIEAN
IHRQQEELRKIQEQLQMVHGQGLQMFLQQSNPGLNFGSVQLSSGNSSNIQQLAPINMQGQ
VVPTNQIQSGMNTGHIGTTQHMIQQQTLQSTSTQSQQNVLSGHSQQTSLPSQTQSTLTAP
LYNTMVISQPAAGSMVQIPSSMPQNSTQSAAVTTFTQDRQIRFSQGQQLVTKLVTAPVAC
GAVMVPSTMLMGQVVTAYPTFATQQQQSQTLSVTQQQQQQSSQEQQLTSVQQPSQAQLTQ
PPQQFLQTSRLLHGNPSTQLILSAAFPLQQSTFPQSHHQQHQSQQQQQLSRHRTDSLPDP
SKVQPQ
Function
Transcriptional activator which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. Regulates the circadian expression of ICAM1, VCAM1, CCL2, THPO and MPL and also acts as an enhancer of the transactivation potential of NF-kappaB. Plays an important role in the homeostatic regulation of sleep. The CLOCK-BMAL1 heterodimer regulates the circadian expression of SERPINE1/PAI1, VWF, B3, CCRN4L/NOC, NAMPT, DBP, MYOD1, PPARGC1A, PPARGC1B, SIRT1, GYS2, F7, NGFR, GNRHR, BHLHE40/DEC1, ATF4, MTA1, KLF10 and also genes implicated in glucose and lipid metabolism. Promotes rhythmic chromatin opening, regulating the DNA accessibility of other transcription factors. The CLOCK-BMAL2 heterodimer activates the transcription of SERPINE1/PAI1 and BHLHE40/DEC1. The preferred binding motif for the CLOCK-BMAL1 heterodimer is 5'-CACGTGA-3', which contains a flanking adenine nucleotide at the 3-prime end of the canonical 6-nucleotide E-box sequence. CLOCK specifically binds to the half-site 5'-CAC-3', while BMAL1 binds to the half-site 5'-GTGA-3'. The CLOCK-BMAL1 heterodimer also recognizes the non-canonical E-box motifs 5'-AACGTGA-3' and 5'-CATGTGA-3'. CLOCK has an intrinsic acetyltransferase activity, which enables circadian chromatin remodeling by acetylating histones and nonhistone proteins, including its own partner BMAL1. Represses glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) via the acetylation of multiple lysine residues located in its hinge region. The acetyltransferase activity of CLOCK is as important as its transcription activity in circadian control. Acetylates metabolic enzymes IMPDH2 and NDUFA9 in a circadian manner. Facilitated by BMAL1, rhythmically interacts and acetylates argininosuccinate synthase 1 (ASS1) leading to enzymatic inhibition of ASS1 as well as the circadian oscillation of arginine biosynthesis and subsequent ureagenesis. Drives the circadian rhythm of blood pressure through transcriptional activation of ATP1B1.
Tissue Specificity
Hair follicles (at protein level). Expressed in all tissues examined including spleen, thymus, prostate, testis, ovary, small intestine, colon, leukocytes, heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas. Highest levels in testis and skeletal muscle. Low levels in thymus, lung and liver. Expressed in all brain regions with highest levels in cerebellum. Highly expressed in the suprachiasmatic nucleus (SCN).
KEGG Pathway
Circadian rhythm (hsa04710 )
Dopaminergic sy.pse (hsa04728 )
Reactome Pathway
PPARA activates gene expression (R-HSA-1989781 )
HATs acetylate histones (R-HSA-3214847 )
Circadian Clock (R-HSA-400253 )
Heme signaling (R-HSA-9707616 )
BMAL1 (R-HSA-1368108 )

Molecular Interaction Atlas (MIA) of This DOT

46 Disease(s) Related to This DOT
Disease Name Disease ID Evidence Level Mode of Inheritance REF
Epilepsy DISBB28L Definitive Biomarker [1]
Obstructive sleep apnea DIS0SVD1 Definitive Genetic Variation [2]
Adenoma DIS78ZEV Strong Genetic Variation [3]
Advanced cancer DISAT1Z9 Strong Genetic Variation [4]
Alcohol dependence DIS4ZSCO Strong Biomarker [5]
Alcohol withdrawal delirium DISFPH28 Strong Biomarker [5]
Anxiety disorder DISBI2BT Strong Biomarker [6]
Arteriosclerosis DISK5QGC Strong Genetic Variation [7]
Atherosclerosis DISMN9J3 Strong Genetic Variation [7]
Bipolar depression DISA75FU Strong Genetic Variation [8]
Bipolar disorder DISAM7J2 Strong Posttranslational Modification [9]
Bone osteosarcoma DIST1004 Strong Biomarker [10]
Carcinoma DISH9F1N Strong Altered Expression [11]
Cholestasis DISDJJWE Strong Biomarker [12]
Cluster headache DISKAXY9 Strong Genetic Variation [13]
Colorectal carcinoma DIS5PYL0 Strong Biomarker [14]
Depression DIS3XJ69 Strong Altered Expression [15]
Epithelial ovarian cancer DIS56MH2 Strong Biomarker [16]
Gastric cancer DISXGOUK Strong Genetic Variation [17]
Head-neck squamous cell carcinoma DISF7P24 Strong Altered Expression [18]
Hepatocellular carcinoma DIS0J828 Strong Genetic Variation [19]
Insomnia DIS0AFR7 Strong Altered Expression [20]
Metabolic disorder DIS71G5H Strong Genetic Variation [21]
Neoplasm DISZKGEW Strong Biomarker [4]
Non-small-cell lung cancer DIS5Y6R9 Strong Biomarker [22]
Osteoarthritis DIS05URM Strong Biomarker [23]
Osteosarcoma DISLQ7E2 Strong Biomarker [10]
Parkinson disease DISQVHKL Strong Altered Expression [24]
Rheumatoid arthritis DISTSB4J Strong Biomarker [25]
Seasonal affective disorder DIS908VO Strong Biomarker [26]
Smith-Magenis syndrome DISG4G6X Strong Genetic Variation [27]
Squamous cell carcinoma DISQVIFL Strong Biomarker [22]
Stomach cancer DISKIJSX Strong Genetic Variation [17]
Asthma DISW9QNS moderate Altered Expression [28]
Attention deficit hyperactivity disorder DISL8MX9 moderate Biomarker [29]
High blood pressure DISY2OHH moderate Biomarker [30]
Acute myelogenous leukaemia DISCSPTN Disputed Biomarker [31]
Alcohol use disorder DISMB65Y Disputed Genetic Variation [32]
Melanoma DIS1RRCY Disputed Genetic Variation [33]
Autism spectrum disorder DISXK8NV Limited Biomarker [34]
Cocaine addiction DISHTRXG Limited Genetic Variation [35]
Coronary heart disease DIS5OIP1 Limited Altered Expression [36]
Inflammatory bowel disease DISGN23E Limited Genetic Variation [37]
Mental disorder DIS3J5R8 Limited Biomarker [38]
Myocardial infarction DIS655KI Limited Genetic Variation [39]
Pancreatic cancer DISJC981 Limited Altered Expression [40]
------------------------------------------------------------------------------------
⏷ Show the Full List of 46 Disease(s)
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
This DOT Affected the Drug Response of 1 Drug(s)
Drug Name Drug ID Highest Status Interaction REF
Clozapine DMFC71L Approved Circadian locomoter output cycles protein kaput (CLOCK) affects the response to substance of Clozapine. [50]
------------------------------------------------------------------------------------
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the methylation of Circadian locomoter output cycles protein kaput (CLOCK). [41]
PMID28870136-Compound-52 DMFDERP Patented PMID28870136-Compound-52 decreases the phosphorylation of Circadian locomoter output cycles protein kaput (CLOCK). [48]
------------------------------------------------------------------------------------
7 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Doxorubicin DMVP5YE Approved Doxorubicin decreases the expression of Circadian locomoter output cycles protein kaput (CLOCK). [42]
Cisplatin DMRHGI9 Approved Cisplatin decreases the expression of Circadian locomoter output cycles protein kaput (CLOCK). [43]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Circadian locomoter output cycles protein kaput (CLOCK). [44]
Dexamethasone DMMWZET Approved Dexamethasone affects the expression of Circadian locomoter output cycles protein kaput (CLOCK). [45]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the expression of Circadian locomoter output cycles protein kaput (CLOCK). [46]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 increases the expression of Circadian locomoter output cycles protein kaput (CLOCK). [47]
CGS 21680 DMZ0TGY Investigative CGS 21680 increases the expression of Circadian locomoter output cycles protein kaput (CLOCK). [49]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Drug(s)

References

1 Altered circadian rhythms and oscillation of clock genes and sirtuin 1 in a model of sudden unexpected death in epilepsy.Epilepsia. 2018 Aug;59(8):1527-1539. doi: 10.1111/epi.14513. Epub 2018 Jul 15.
2 Alternations of Circadian Clock Genes Expression and Oscillation in Obstructive Sleep Apnea.J Clin Med. 2019 Oct 6;8(10):1634. doi: 10.3390/jcm8101634.
3 Case-control study of candidate gene methylation and adenomatous polyp formation.Int J Colorectal Dis. 2017 Feb;32(2):183-192. doi: 10.1007/s00384-016-2688-1. Epub 2016 Oct 22.
4 Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link.Biochem Genet. 2020 Feb;58(1):189-209. doi: 10.1007/s10528-019-09938-w. Epub 2019 Sep 24.
5 Reduced expression of circadian clock genes in male alcoholic patients.Alcohol Clin Exp Res. 2010 Nov;34(11):1899-904. doi: 10.1111/j.1530-0277.2010.01278.x. Epub 2010 Aug 24.
6 The role of clock genes in the etiology of Major Depressive Disorder: Special Section on "Translational and Neuroscience Studies in Affective Disorders". Section Editor, Maria Nobile MD, PhD. This Section of JAD focuses on the relevance of translational and neuroscience studies in providing a better understanding of the neural basis of affective disorders. The main aim is to briefly summaries relevant research findings in clinical neuroscience with particular regards to specific innovative topics in mood and anxiety disorders.J Affect Disord. 2018 Jul;234:351-357. doi: 10.1016/j.jad.2017.11.015. Epub 2017 Nov 7.
7 Angiotensin II Suppresses Rev-erb Expression in THP-1 Macrophages via the Ang II Type 1 Receptor/Liver X Receptor Pathway.Cell Physiol Biochem. 2018;46(1):303-313. doi: 10.1159/000488431. Epub 2018 Mar 22.
8 CLOCK gene variants associated with the discrepancy between subjective and objective severity in bipolar depression.J Affect Disord. 2017 Mar 1;210:14-18. doi: 10.1016/j.jad.2016.12.007. Epub 2016 Dec 13.
9 Epigenetics of the molecular clock and bacterial diversity in bipolar disorder.Psychoneuroendocrinology. 2019 Mar;101:160-166. doi: 10.1016/j.psyneuen.2018.11.009. Epub 2018 Nov 10.
10 Cryptochrome 2 (CRY2) Suppresses Proliferation and Migration and Regulates Clock Gene Network in Osteosarcoma Cells.Med Sci Monit. 2018 Jun 7;24:3856-3862. doi: 10.12659/MSM.908596.
11 Expression of circadian clock genes in human colorectal adenoma and carcinoma.Oncol Lett. 2017 Nov;14(5):5319-5325. doi: 10.3892/ol.2017.6876. Epub 2017 Sep 4.
12 Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.Am J Physiol Gastrointest Liver Physiol. 2011 Oct;301(4):G634-43. doi: 10.1152/ajpgi.00206.2011. Epub 2011 Jul 14.
13 Genetic association of HCRTR2, ADH4 and CLOCK genes with cluster headache: a Chinese population-based case-control study.J Headache Pain. 2018 Jan 9;19(1):1. doi: 10.1186/s10194-017-0831-1.
14 Identification and meta-analysis of copy number variation-driven circadian clock genes for colorectal cancer.Oncol Lett. 2019 Nov;18(5):4816-4824. doi: 10.3892/ol.2019.10830. Epub 2019 Sep 9.
15 Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment.Psychopharmacology (Berl). 2018 Mar;235(3):627-640. doi: 10.1007/s00213-017-4781-8. Epub 2017 Nov 19.
16 Circadian Gene CLOCK Affects Drug-Resistant Gene Expression and Cell Proliferation in Ovarian Cancer SKOV3/DDP Cell Lines Through Autophagy.Cancer Biother Radiopharm. 2017 May;32(4):139-146. doi: 10.1089/cbr.2016.2153.
17 Functional polymorphisms in circadian positive feedback loop genes predict postsurgical prognosis of gastric cancer.Cancer Med. 2019 Apr;8(4):1919-1929. doi: 10.1002/cam4.2050. Epub 2019 Mar 7.
18 PER1 and CLOCK: potential circulating biomarkers for head and neck squamous cell carcinoma.Head Neck. 2014 Jul;36(7):1018-26. doi: 10.1002/hed.23402. Epub 2013 Sep 12.
19 Critical cholangiocarcinogenesis control by cryptochrome clock genes.Int J Cancer. 2017 Jun 1;140(11):2473-2483. doi: 10.1002/ijc.30663. Epub 2017 Mar 16.
20 Sleep Disturbance and Altered Expression of Circadian Clock Genes in Patients With Sudden Sensorineural Hearing Loss.Medicine (Baltimore). 2015 Jul;94(26):e978. doi: 10.1097/MD.0000000000000978.
21 Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.Expert Rev Clin Pharmacol. 2020 Jan;13(1):23-34. doi: 10.1080/17512433.2020.1698288. Epub 2020 Jan 3.
22 Research on circadian clock genes in non-small-cell lung carcinoma.Chronobiol Int. 2019 Jun;36(6):739-750. doi: 10.1080/07420528.2018.1509080. Epub 2019 Apr 24.
23 Pharmacological targeting of the mammalian clock reveals a novel analgesic for osteoarthritis-induced pain.Gene. 2018 May 20;655:1-12. doi: 10.1016/j.gene.2018.02.048. Epub 2018 Feb 20.
24 Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism.Int J Mol Sci. 2019 Jun 5;20(11):2772. doi: 10.3390/ijms20112772.
25 Expressions of circadian clock genes represent disease activities of RA patients treated with biological DMARDs.Mod Rheumatol. 2020 Mar;30(2):293-300. doi: 10.1080/14397595.2019.1602242. Epub 2019 May 2.
26 Genetics of circadian rhythms and mood spectrum disorders.Eur Neuropsychopharmacol. 2011 Sep;21 Suppl 4:S676-82. doi: 10.1016/j.euroneuro.2011.07.007. Epub 2011 Aug 10.
27 Smith-Magenis syndrome.Handb Clin Neurol. 2013;111:295-6. doi: 10.1016/B978-0-444-52891-9.00034-8.
28 Circadian timing in the lung; a specific role for bronchiolar epithelial cells.Endocrinology. 2009 Jan;150(1):268-76. doi: 10.1210/en.2008-0638. Epub 2008 Sep 11.
29 Clock genes, ADHD and aggression.Neurosci Biobehav Rev. 2018 Aug;91:51-68. doi: 10.1016/j.neubiorev.2016.11.002. Epub 2016 Nov 9.
30 Female C57BL/6J mice lacking the circadian clock protein PER1 are protected from nondipping hypertension.Am J Physiol Regul Integr Comp Physiol. 2019 Jan 1;316(1):R50-R58. doi: 10.1152/ajpregu.00381.2017. Epub 2018 Nov 14.
31 Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML.Cell. 2016 Apr 7;165(2):303-16. doi: 10.1016/j.cell.2016.03.015.
32 Clock genes polymorphisms in male bipolar patients with comorbid alcohol abuse.J Affect Disord. 2018 Dec 1;241:142-146. doi: 10.1016/j.jad.2018.07.080. Epub 2018 Jul 31.
33 A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma.Exp Biol Med (Maywood). 2017 Sep;242(15):1553-1558. doi: 10.1177/1535370217724093. Epub 2017 Aug 11.
34 Dysregulation of Circadian Rhythms in Autism Spectrum Disorders.Curr Pharm Des. 2019;25(41):4379-4393. doi: 10.2174/1381612825666191102170450.
35 Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM-IV cocaine dependence as traits for genetic association analysis.Am J Med Genet B Neuropsychiatr Genet. 2014 Mar;165B(2):148-56. doi: 10.1002/ajmg.b.32216. Epub 2013 Dec 11.
36 Does exercise training impact clock genes in patients with coronary artery disease and type 2 diabetes mellitus?.Eur J Prev Cardiol. 2016 Sep;23(13):1375-82. doi: 10.1177/2047487316639682. Epub 2016 Mar 21.
37 Clock Gene Disruption Is an Initial Manifestation of Inflammatory Bowel Diseases.Clin Gastroenterol Hepatol. 2020 Jan;18(1):115-122.e1. doi: 10.1016/j.cgh.2019.04.013. Epub 2019 Apr 10.
38 The role of CLOCK gene in psychiatric disorders: Evidence from human and animal research.Am J Med Genet B Neuropsychiatr Genet. 2018 Mar;177(2):181-198. doi: 10.1002/ajmg.b.32599. Epub 2017 Sep 13.
39 Circadian clock genes and circadian phenotypes in patients with myocardial infarction.Adv Med Sci. 2019 Sep;64(2):224-229. doi: 10.1016/j.advms.2018.12.003. Epub 2019 Feb 26.
40 Research progress on circadian clock genes in common abdominal malignant tumors.Oncol Lett. 2017 Nov;14(5):5091-5098. doi: 10.3892/ol.2017.6856. Epub 2017 Aug 31.
41 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
42 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
43 Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin. EMBO J. 2011 Feb 2;30(3):510-23. doi: 10.1038/emboj.2010.333. Epub 2010 Dec 14.
44 Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110:189-199. doi: 10.1016/j.fct.2017.10.031. Epub 2017 Oct 20.
45 Glucocorticoids affect 24 h clock genes expression in human adipose tissue explant cultures. PLoS One. 2012;7(12):e50435. doi: 10.1371/journal.pone.0050435. Epub 2012 Dec 10.
46 Gene expression changes associated with altered growth and differentiation in benzo[a]pyrene or arsenic exposed normal human epidermal keratinocytes. J Appl Toxicol. 2008 May;28(4):491-508.
47 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
48 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
49 Adenosine A2A receptor and TNF- regulate the circadian machinery of the human monocytic THP-1 cells. Inflammation. 2013 Feb;36(1):152-62. doi: 10.1007/s10753-012-9530-x.
50 Genetic dissection of drug effects in clinical practice: CLOCK gene and clozapine-induced diurnal sleepiness. Neurosci Lett. 2004 Sep 2;367(2):152-5. doi: 10.1016/j.neulet.2004.05.084.